Table 2 Liver attenuation.
Liver attenuation | ||
|---|---|---|
All patients | TNC | 58.8 ± 9.0 |
VNC-Chest | 56.1 ± 8.0 | |
VNC-Abdomen | 59.1 ± 6.3 | |
Difference of TNC and VNC-Chest | 2.7 ± 5.8 | |
Difference of TNC and VNC-Abdomen | −0.3 ± 6.7 | |
Patients without Amiodarone treatment | TNC | 58.1 ± 8.6 |
VNC-Chest | 56.3 ± 8.3 | |
VNC-Abdomen | 59.2 ± 6.4 | |
Difference of TNC and VNC-Chest | 1.8 ± 4.6 | |
Difference of TNC and VNC-Abdomen | −1.1 ± 5.6 | |
Patients with Amiodarone treatment | TNC | 63.1 ± 9.8 |
VNC-Chest | 55.3 ± 5.8 | |
VNC-Abdomen | 58.7 ± 5.8 | |
Difference of TNC and VNC-Chest | 7.7 ± 8.9 | |
Difference of TNC and VNC-Abdomen | 4.3 ± 10.2 | |
p-values | ||
Patients with Amiodarone treatment vs. no Amiodarone | TNC | p = 0.04 |
VNC-Chest | p = 0.35 | |
VNC-Abdomen | p = 0.62 | |
Difference of TNC and VNC-Chest | p = 0.002 | |
Difference of TNC and VNC-Abdomen | p = 0.004 | |
